欧盟HMA药品数据库（European Union HMA Authorisation of Medicines DataBase）
MR编号
PT/H/1192/001
药品名称
Aciclovir Hikma
活性成分
aciclovir 250.0 mg
剂型
Powder for solution for infusion
上市许可持有人
Hikma Farmacêutica (Portugal), S.A.
参考成员国 - 产品名称
Portugal (PT)
互认成员国 - 产品名称
Germany (DE)
Aciclovir Hikma 250 mg Pulver zur Herstellung einer Infusionslösung
Italy (IT)
United Kingdom (Northern Ireland) (XI)
France (FR)
Spain (ES)
Poland (PL)
Aciclovir Hikma
Belgium (BE)
Aciclovir Hikma 250 mg poudre pour solution pour perfusion
Netherlands (NL)
Austria (AT)
许可日期
2014/10/14
最近更新日期
2023/08/12
药物ATC编码
J05AB01 aciclovir
申请类型
TypeLevel1：
Known Active Substance
TypeLevel2：
Initial Application
TypeLevel3：
Generic Art 10.1 and 10.2 Dir 2001/83/EC
TypeLevel4：
Chemical Substance
TypeLevel5：
Prescription Only
附件文件下载
Final Product Information
|
common-impack-aciclovir
Date of last change:2016/09/29
Final Product Information
|
common-outer-aciclovir-clean
Date of last change:2016/09/29
Final Product Information
|
common-pl-aciclovir-clean
Date of last change:2016/09/29
Final Product Information
|
common-spc-aciclovir-clean
Date of last change:2016/09/29
Final Labelling
|
579720_579721_20150424_ROT_RCM
Date of last change:2015/04/25
Final PL
|
579720_579721_20150424_FI_RCM
Date of last change:2015/04/25
Final SPC
|
579720_579721_20150424_RCM_RCM
Date of last change:2015/04/25
PAR
|
579720_579721_20150424_PAR_RCM
Date of last change:2015/04/25
市场状态
Positive
©2006-2024
Drugfuture
->
European Union HMA Authorisation of Medicines DataBase